Orthofix International N.V. (NASDAQ:OFIX) insider Bradley V. Niemann sold 5,547 shares of the company’s stock in a transaction on Monday, December 11th. The shares were sold at an average price of $52.08, for a total value of $288,887.76. Following the sale, the insider now owns 34,631 shares of the company’s stock, valued at approximately $1,803,582.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Shares of Orthofix International N.V. (NASDAQ:OFIX) traded down $0.13 on Wednesday, reaching $51.81. The company’s stock had a trading volume of 60,400 shares, compared to its average volume of 146,692. The stock has a market capitalization of $946.92, a PE ratio of 33.95, a price-to-earnings-growth ratio of 2.58 and a beta of 0.14. Orthofix International N.V. has a fifty-two week low of $32.51 and a fifty-two week high of $54.73.
Orthofix International (NASDAQ:OFIX) last issued its quarterly earnings results on Monday, October 30th. The medical device company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. The business had revenue of $105.30 million during the quarter, compared to analysts’ expectations of $100.67 million. Orthofix International had a return on equity of 10.26% and a net margin of 0.33%. The business’s quarterly revenue was up 6.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.36 earnings per share. equities analysts forecast that Orthofix International N.V. will post 1.61 earnings per share for the current fiscal year.
OFIX has been the subject of a number of research reports. TheStreet cut Orthofix International from a “b” rating to a “c+” rating in a research report on Tuesday, October 31st. Zacks Investment Research cut Orthofix International from a “buy” rating to a “hold” rating in a research report on Wednesday, November 8th. BTIG Research set a $56.00 price target on Orthofix International and gave the stock a “buy” rating in a research report on Monday, October 30th. Finally, BidaskClub upgraded Orthofix International from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. One research analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Orthofix International presently has a consensus rating of “Buy” and an average target price of $54.42.
A number of institutional investors and hedge funds have recently modified their holdings of OFIX. Bank of America Corp DE increased its position in Orthofix International by 834.2% in the first quarter. Bank of America Corp DE now owns 28,838 shares of the medical device company’s stock worth $1,100,000 after buying an additional 25,751 shares in the last quarter. State Street Corp boosted its stake in shares of Orthofix International by 27.0% in the first quarter. State Street Corp now owns 462,479 shares of the medical device company’s stock worth $17,640,000 after acquiring an additional 98,212 shares during the period. Aperio Group LLC boosted its stake in shares of Orthofix International by 23.4% in the second quarter. Aperio Group LLC now owns 15,316 shares of the medical device company’s stock worth $712,000 after acquiring an additional 2,902 shares during the period. Municipal Employees Retirement System of Michigan bought a new position in shares of Orthofix International in the second quarter worth about $196,000. Finally, Texas Permanent School Fund boosted its stake in shares of Orthofix International by 41.5% in the second quarter. Texas Permanent School Fund now owns 13,174 shares of the medical device company’s stock worth $612,000 after acquiring an additional 3,867 shares during the period. Institutional investors and hedge funds own 94.61% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Bradley V. Niemann Sells 5,547 Shares of Orthofix International N.V. (OFIX) Stock” was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this news story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this news story can be read at https://ledgergazette.com/2017/12/13/bradley-v-niemann-sells-5547-shares-of-orthofix-international-n-v-ofix-stock.html.
Orthofix International Company Profile
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Receive News & Ratings for Orthofix International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International and related companies with MarketBeat.com's FREE daily email newsletter.